Page 2 - Best Chondrosarcoma doctors: TOP 49 doctors

Dr. Amir is a specialist in limb-sparing surgery for bone and soft tissue cancers at Israel's Sourasky Medical Center (Ichilov).

• Fellowship-trained in orthopedic oncology at the US National Cancer Institute and the University of Toronto
• Active member of the American Musculoskeletal Tumor Society (MSTS) and the International Society of Limb Salvage (ISOLS)
• Multiple award winner, including the Tannenbaum Grant for Excellence in Surgical Oncology
• Focuses on sarcomas, with expertise in complex cases requiring reconstructive techniques

Heads a department dedicated to metastatic bone lesions at Ichilov Medical Center – one of Israel's largest hospitals.

• Specializes exclusively in oncological orthopedics, treating bone cancers.
• Completed advanced clinical internships in Israel and the United States.
• Holds a senior academic position as a Professor at Tel Aviv University.
• Educated at the prestigious Hebrew University of Jerusalem.

Professor Keil leads the Clinic for Diagnostic and Interventional Radiology at Academic Hospital Solingen, specializing in advanced imaging for complex cases.

• Graduated with honors from Julius-Maximilians-Universität Würzburg
• Expert in MRI, CT, and ultrasound-guided interventions
• Former leading doctor at University Hospital of Aachen
• Specializes in cross-sectional imaging for all body regions

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Assoc. Prof. Nail Paksoy brings specialized expertise in bone sarcomas from Istanbul University Oncology Institute, now leading chondrosarcoma care at Medipol Bahçelievler Hospital.

• Board-certified in medical oncology by ESMO
• Authored key research on high-dose chemotherapy for Ewing's sarcoma and other bone tumors
• Participated in international trials for NTRK-fusion solid tumors
• Fellowship-trained at one of Turkey's premier oncology centers

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Specializing in virotherapy – one of the newest immunology fields – Dr. Jaunalksne brings 49 years of experience of experience to treating chondrosarcoma.

• Head of Clinical Immunology Center at Pauls Stradins Clinical University Hospital
• Graduate of Riga Medical Institute with internship in Internal Medicine
• Focuses on innovative immunological approaches to cancer treatment

Specialized in radiation oncology at Marmara University, focusing on chondrosarcoma treatment.

• Trained at renowned Marmara University Faculty of Medicine
• Specialization in radiation oncology from 2012-2016
• Graduated from Marmara University Faculty of Medicine (English) undergraduate program
• Dedicated to providing personalized radiation therapy plans

Associate Professor Dr. Emrah Eraslan specializes in oncology with extensive experience in treating various cancers, including Chondrosarcoma, at Koru Ankara Hospital.

• Board-certified in internal medicine and medical oncology
• Trained at Dr. Abdurrahman Yurtaslan Ankara Oncology Education and Research Hospital
• Published multiple research papers in oncology
• Current associate professor contributing to advancements in cancer treatment

50,000+ cancer surgeries over 30 years of experience – Dr. Nagarkar specializes in complex tumor removal while preserving quality of life at HCG Manavata Cancer Centre.

• Trained at Tata Memorial Hospital and Royal College of Surgeons
• Conducted 200+ clinical trials on new cancer treatments
• Professor for DNB Superspecialty Surgical Oncology
• Special focus on breast and thoracic oncology